Polymorphisms of HIV-2 integrase and selection of resistance to raltegravir

被引：0
|
作者：
Danielle Perez-Bercoff
Perrine Triqueneaux
Christine Lambert
Aboubacar Alassane Oumar
Anne-Marie Ternes
Sounkalo Dao
Patrick Goubau
Jean-Claude Schmit
Jean Ruelle
机构：
[1] CRP-Santé,Laboratoire de Rétrovirologie
[2] AIDS Reference Laboratory,UCLouvain
[3] de Pharmacie et d'Odontostomatologie de Bamako,Faculté de Médecine
[4] International center of Excellence Research Mali (ICER-Mali),undefined
来源：
Retrovirology | / 7卷
关键词：
Human Immunodeficiency Virus Type; Raltegravir; Replicative Capacity; Elvitegravir; I175M Mutation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Resistance to raltegravir highlights integrase mutations at codon 148 in conferring cross-resistance to a second-generation HIV-1 integrase inhibitor
    Goethals, Olivia
    Van Ginderen, Marcia
    Vos, Ann
    Cummings, Maxwell D.
    Van Der Borght, Koen
    Van Wesenbeeck, Liesbeth
    Feyaerts, Maxim
    Verheyen, Ann
    Smits, Veerle
    Van Loock, Marnix
    Hertogs, Kurt
    Schols, Dominique
    Clayton, Reginald F.
    ANTIVIRAL RESEARCH, 2011, 91 (02) : 167 - 176
  • [42] The polymorphisms in chemokine receptors genes and HIV-2 infection
    Arajo, FM
    Miranda, M
    Koch, MC
    Henriques, I
    Monteiro, F
    Meireles, E
    Lacerda, P
    Pereira, C
    Cunha-Ribeiro, LM
    TRANSFUSION, 2000, 40 (10) : 84S - 85S
  • [43] Raltegravir: the first in a new class of integrase inhibitors for the treatment of HIV
    Sayana, Shilpa
    Khanlou, Homayoon
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2008, 6 (04) : 419 - 426
  • [44] DOCKING OF RALTEGRAVIR TO HIV-1 INTEGRASE STRUCTURE ENSEMBLE
    Wei, Caiyi
    Liu, Zeyu
    Zhang, Dawei
    Mei, Ye
    JOURNAL OF THEORETICAL & COMPUTATIONAL CHEMISTRY, 2010, 9 (06): : 1053 - 1063
  • [45] A Facile Synthesis of Raltegravir Potassium-An HIV Integrase Inhibitor
    Karumanchi, Kishore
    Nangi, Gangadhara Bhima Shankar
    Danda, Subba Reddy
    Chavakula, Ramadas
    Korupolu, Raghu Babu
    Bonige, Kishore Babu
    JOURNAL OF HETEROCYCLIC CHEMISTRY, 2019, 56 (09) : 2683 - 2690
  • [46] Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimen
    Roquebert, Benedicte
    Blum, Laurent
    Collin, Gilles
    Damond, Florence
    Peytavin, Gilles
    Leleu, Juliette
    Matheron, Sophie
    Chene, Genevieve
    Brun-Vezinet, Francoise
    Descamps, Diane
    AIDS, 2008, 22 (15) : 2045 - 2046
  • [47] Prevalence of HIV-1 integrase mutations related to resistance to dolutegravir in raltegravir naive and pretreated patients
    Saladini, F.
    Meini, G.
    Bianco, C.
    Monno, L.
    Punzi, G.
    Pecorari, M.
    Borghi, V.
    Di Pietro, M.
    Filice, G.
    Gismondo, M. R.
    Micheli, V.
    Penco, G.
    Carli, T.
    De Luca, A.
    Zazzi, M.
    CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (10) : E428 - E430
  • [48] Single Mutations in HIV Integrase Confer High-Level Resistance to Raltegravir in Primary Human Macrophages
    Marsden, Matthew D.
    Avancena, Patricia
    Kitchen, Christina M. R.
    Hubbard, Trish
    Zack, Jerome A.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (08) : 3696 - 3702
  • [49] Impact of Y143 HIV-1 Integrase Mutations on Resistance to Raltegravir In Vitro and In Vivo
    Delelis, Olivier
    Thierry, Sylvain
    Subra, Frederic
    Simon, Francoise
    Malet, Isabelle
    Alloui, Chakib
    Sayon, Sophie
    Calvez, Vincent
    Deprez, Eric
    Marcelin, Anne-Genevieve
    Tchertanov, Luba
    Mouscadet, Jean-Francois
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2010, 54 (01) : 491 - 501
  • [50] Usefulness of Integrase resistance testing in proviral HIV-1 DNA in patients with Raltegravir prior failure
    Jose Ángel Fernández-Caballero
    Natalia Chueca
    Marta Álvarez
    María Dolores Mérida
    Josefa López
    José Antonio Sánchez
    David Vinuesa
    María Ángeles Martínez
    José Hernández
    Federico García
    BMC Infectious Diseases, 16
12345